543828 — Sudarshan Pharma Industries Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹2.89bn
- IN₹3.92bn
- IN₹4.64bn
- 39
- 40
- 85
- 56
Annual cashflow statement for Sudarshan Pharma Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 35.7 | 71.9 | 95 | 152 |
| Depreciation | ||||
| Non-Cash Items | 32.1 | 32.3 | 49.3 | 81.8 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | -47.6 | -150 | -441 | -186 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 27.7 | -37.4 | -288 | 60.1 |
| Capital Expenditures | -13.2 | -11.2 | -143 | -19.2 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0.253 | -3.66 | -113 | -35.8 |
| Acquisition of Business | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -12.9 | -14.9 | -257 | -54.9 |
| Financing Cash Flow Items | -31.8 | -34.8 | -54 | -89.4 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -14.9 | 42.1 | 659 | -121 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.138 | -10.2 | 115 | -116 |